BY OUR PLATFORMS
BY THERAPEUTIC AREA
31 August 2023
We explore animal alternatives, particularly zebrafish larval models, along with advanced Crispr/Cas9 techniques, streamlining epilepsy modeling and antiepileptic drug trials.
01 December 2022 - 30 November 2025
The project will use patient derived-iPSC and CRISPR-edited human IPSC to develop a novel three-dimensional microfluidic system for drug discovery.
15 November 2022
03 October 2022
01 October 2022 - 30 September 2027
The EdiGenT consortium will work to develop a new generation of more efficient gene correction tools based on the CRISPR/Cas9 system, and non-viral delivery strategies for gene therapy.
17 September 2022
16 September 2022
09 May 2022
11 March 2022
The NTP’s SEAZIT undertook a collaborative exercise to evaluate how the application of standardized phenotype terminology improved data consistency.
07 March 2022
We demonstrate the highly conserved nature of NGF canonical pathway in zebrafish and thus support the use of zebrafish models for testing new compounds with potential retinal regenerative properties.
01 January 2022 - 30 June 2023
ZeBYTE aims at using artificial intelligence technologies along the whole target discovery process.
18 October 2021
01 August 2021 - 01 August 2023
A cutting-edge gene-editing platform to generate complex disease models to test innovative therapeutic approaches.
16 June 2021
01 April 2021 - 31 March 2024
The ROBO-FISH consortium will develop and validate injection and imaging robots to automate oncology drug screening in zebrafish to mimic human disease.
12 March 2021
Please leave your details in the form below.